DOI QR코드

DOI QR Code

Meta-analysis of the Association Between GSTM1 and GSTT1 Gene Polymorphisms and Cervical Cancer

  • Zhang, Zhen-Yong (Oncology Department of Shengjing Hospital affiliated to China Medical University) ;
  • Jin, Xue-Ying (Oncology Department of Shengjing Hospital affiliated to China Medical University) ;
  • Wu, Rong (Oncology Department of Shengjing Hospital affiliated to China Medical University) ;
  • Wu, Li-Na (Oncology Department of Shengjing Hospital affiliated to China Medical University) ;
  • Xing, Rui (Oncology Department of Shengjing Hospital affiliated to China Medical University) ;
  • Yang, Shu-Juan (West China School of Public Health, Sichuan University) ;
  • Xie, Yao (West China School of Public Health, Sichuan University)
  • Published : 2012.03.31

Abstract

Aim: We conducted a meta-analysis to analyze the influence of GSTM1 and GSTT1 gene polymorphisms on cervical cancer risk, and explore gene-environment interactions. Methods: Identification of relevant studies was carried out through a search of Medline and the EMbase up to Oct. 2011. All case-control studies that investigated the association between GSTM1 and GSTT1 gene polymorphisms and risk of cervical cancer were included. The pooled odds ratio (OR) was used for analyses of results and the corresponding 95% confidence intervals (CI) were estimated. Results: A total of 21 case-control studies were included in the meta-analysis of GSTM1 (2,378 cases and 2,639 controls) and GSTT1 (1,229 cases and 1,223 controls) genotypes. The overall results showed that the GSTM1 null was related to an increased risk of cervical cancer (OR=1.50, 95% CI=1.21-1.85). Subgroup analysis were performed based on smoking and ethnicity. Our results showed that smokers with null GSTM1 genotype had a moderate increased risk of cervical cancer (OR=1.85, 95% CI=1.07-3.20). For the ethnicity stratification, moderate significantly increased risk of null GSTM1 genotype was found in Chinese (OR=2.12, 95% CI=1.43-3.15) and Indian populations (OR=2.07, 95% CI=1.49-2.88), but no increased risk was noted in others. Conclusion: This meta-analysis provided strong evidence that the GSTM1 genotype is associated with the development of cervical cancer, especially in smokers, and Chinese and Indian populations. However, no association was found for GSTT1 null genotype carriers.

References

  1. Agodi A, Barchitta M, Cipresso R, et al (2010). Distribution of p53, GST, and MTHFR polymorphisms and risk of cervical intraepithelial lesions in sicily. Int J Gynecol Cancer, 20, 141-6. https://doi.org/10.1111/IGC.0b013e3181c20842
  2. Begg CB, Mazumdar M (1994). Operating characteristics of a rank correlation test for publication bias. Biometrics, 50, 1088-101. https://doi.org/10.2307/2533446
  3. Carlsten C, Sagoo GS, Frodsham AJ, et al (2008). Glutathione S-transferase M1 (GSTM1) polymorphisms and lung cancer: a literature-based systematic HuGE review and meta-analysis. Am J Epidemiol, 167, 759-74. https://doi.org/10.1093/aje/kwm383
  4. Chen C, Madeleine MM, Weiss NS, et al (1999). Glutathione S-transferase M1 genotypes and the risk of squamous carcinoma of the cervix: a population-based case-control study. Am J Epidemiol, 150, 568-72. https://doi.org/10.1093/oxfordjournals.aje.a010054
  5. Der Simonian R, Laird N(1986). Meta-analysis in clinical trials. Control Clin Trials, 7, 177-88. https://doi.org/10.1016/0197-2456(86)90046-2
  6. Egger M, Davey Smith G, Schneider M, et al (1997). Bias in meta-analysis detected by a simple, graphical test. BMJ, 315, 629-34. https://doi.org/10.1136/bmj.315.7109.629
  7. Hayes JD, Pulford DJ (1995). The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. Crit Rev Biochem Mol Biol, 30, 445-600. https://doi.org/10.3109/10409239509083491
  8. Herrington CS (1999). Do HPV-negative cervical carcinomas exist? J Pathol, 189, 1-3. https://doi.org/10.1002/(SICI)1096-9896(199909)189:1<1::AID-PATH432>3.0.CO;2-P
  9. International Agency for Research on Cancer. Cervical Cancer Incidence and Mortality Worldwide in 2008. 2011; http://globocan.iarc.fr.
  10. Joseph T, Chacko P, Wesley R, et al (2006). Germline genetic polymorphisms of CYP1A1, GSTM1 and GSTT1 genes in Indian cervical cancer: associations with tumor progression, age and human papillomavirus infection. Gynecol Oncol, 101, 411-7. https://doi.org/10.1016/j.ygyno.2005.10.033
  11. Kim JW, Lee CG, Park YG, et al (2000). Combined analysis of germline polymorphisms of p53, GSTM1, GSTT1, CYP1A1, and CYP2E1: relation to the incidence rate of cervical carcinoma. Cancer, 88, 2082-91. https://doi.org/10.1002/(SICI)1097-0142(20000501)88:9<2082::AID-CNCR14>3.0.CO;2-D
  12. Lee SA, Kim JW, Roh JW, et al (2004). Genetic polymorphisms of GSTM1, p21, p53 and HPV infection with cervical cancer in Korean women. Gynecol Oncol, 93, 14-8. https://doi.org/10.1016/j.ygyno.2003.11.045
  13. Landi S (2000). Mammalian class theta GST and differential susceptibility to carcinogens: a review. Mutat Res, 463, 247-283. https://doi.org/10.1016/S1383-5742(00)00050-8
  14. Mo Z, Gao Y, Cao Y (2009). An updating meta-analysis of the GSTM1, GSTT1, and GSTP1 polymorphisms and prostate cancer: a HuGE review. Prostate, 69, 662-88. https://doi.org/10.1002/pros.20907
  15. Mantel N, Haenszel W (1959). Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst, 22, 719-48.
  16. Nishino K, Sekine M, Kodama S, et al (2008). Cigarette smoking and glutathione S-transferase M1 polymorphism associated with risk for uterine cervical cancer. J Obstet Gynaecol Res, 34, 994-1001.
  17. Parl FF(2005). Glutathione S-transferase genotypes and cancer risk. Cancer Lett, 221, 123-129. https://doi.org/10.1016/j.canlet.2004.06.016
  18. Prokopczyk B, Cox JE, Hoffmann D, et al (1997). Identification of tobacco-specific carcinogen in the cervical mucus of smokers and non-smokers. J Natl Cancer Inst, 89, 868-73. https://doi.org/10.1093/jnci/89.12.868
  19. Palma S, Novelli F, Padua L, et al (2010). Interaction between glutathione-S-transferase polymorphisms, smoking habit, and HPV infection in cervical cancer risk. J Cancer Res Clin Oncol, 136, 1101-9. https://doi.org/10.1007/s00432-009-0757-3
  20. Rebbeck TR (1997). Molecular epidemiology of the human glutathione S-transferase genotypes GSTM1 and GSTT1 in cancer susceptibility. Cancer Epidemiol Biomarkers Prev, 6, 733-43.
  21. Settheetham-Ishida W, Yuenyao P, Kularbkaew C, et al (2009). Glutathione S-transferase (GSTM1 and GSTT1) polymorphisms in cervical cancer in Northeastern Thailand. Asian Pac J Cancer Prev, 10, 365-8.
  22. Sharma A, Sharma JK, Murthy NS, et al (2004). Polymorphisms at GSTM1 and GSTT1 gene loci and susceptibility to cervical cancer in Indian population. Neoplasma, 51, 12-6.
  23. Song GY, Song ZY, Xu JP, et al (2008). Association of single nucleotide polymorphism in glutathione S-transferase-M1 with susceptibility to cervical cancer in Shanxi Province. Zhonghua Cancer Prev J, 7, 1054-6.
  24. Sobti RC, Kaur S, Kaur P, et al (2006). Interaction of passive smoking with GST (GSTM1, GSTT1, and GSTP1) genotypes in the risk of cervical cancer in India. Cancer Genet Cytogenet, 166, 117-23. https://doi.org/10.1016/j.cancergencyto.2005.10.001
  25. Singh H, Sachan R, Devi S, et al (2008). Association of GSTM1, GSTT1, and GSTM3 gene polymorphisms and susceptibility to cervical cancer in a North Indian population. Am J Obstet Gynecol, 198, 303.e1-6.
  26. Schiffman M, Castle PE, Jeronimo J, et al (2007). Human papillomavirus and cervical cancer. Lancet, 370, 890-907. https://doi.org/10.1016/S0140-6736(07)61416-0
  27. Ueda M, Hung YC, Terai Y, et al (2005). Glutathione-S-transferase and p53 polymorphisms in cervical carcinogenesis. Gynecol Oncol, 96, 736-40. https://doi.org/10.1016/j.ygyno.2004.11.005
  28. Walboomers JM, Meijer CJ (1997). Do HPV-negative cervical carcinomas exist? J Pathol, 181, 253-4. https://doi.org/10.1002/(SICI)1096-9896(199703)181:3<253::AID-PATH755>3.0.CO;2-0
  29. Walboomers JM, Jacobs MV, Manos MM, et al (1999). Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol, 189, 12-9. https://doi.org/10.1002/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F
  30. Zhuo X, Cai L, Xiang Z (2009). GSTM1 and GSTT1 polymorphisms and nasopharyngeal cancer risk: an evidence-based meta-analysis. J Exp Clin Cancer Res, 28, 46. https://doi.org/10.1186/1756-9966-28-46
  31. Zhou Q, Wang JT, Shao SL (2006). The study of the relationship between glutathione S-transferase M1, T1 genotypes and the risk of cervical cancer. Modern Prev Med, 33, 269-71.

Cited by

  1. Glutathione-S-Transferase T1 Polymorphism is Associated with Esophageal Cancer Risk in Chinese Han Population vol.13, pp.9, 2012, https://doi.org/10.7314/APJCP.2012.13.9.4403
  2. Association of the Glutathione S-Transferase M1, T1 Polymorphisms with Cancer: Evidence from a Meta-Analysis vol.8, pp.11, 2013, https://doi.org/10.1371/journal.pone.0078707
  3. Stratification Analysis and Case-control Study of Relationships between Interleukin-6 Gene Polymorphisms and Cervical Cancer Risk in a Chinese Population vol.15, pp.17, 2014, https://doi.org/10.7314/APJCP.2014.15.17.7357
  4. Glutathione S-Transferase T1 and M1 Polymorphisms and Risk of Uterine Cervical Lesions in Women from Central Serbia vol.15, pp.7, 2014, https://doi.org/10.7314/APJCP.2014.15.7.3201
  5. Glutathione S-transferase M1 and T1 Polymorphisms, Cigarette Smoking and HPV Infection in Precancerous and Cancerous Lesions of the Uterine Cervix vol.16, pp.15, 2015, https://doi.org/10.7314/APJCP.2015.16.15.6429
  6. Lack of Participation of the GSTM1 Polymorphism in Cervical Cancer Development in Northeast Thailand vol.16, pp.5, 2015, https://doi.org/10.7314/APJCP.2015.16.5.1935